Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome.

[1]  W. Jiménez,et al.  Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis , 1995, Hepatology.

[2]  B. Brenner,et al.  Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites , 1994, Hepatology.

[3]  W. Jiménez,et al.  Antidiuretic Hormone and the Pathogenesis of Water Retention in Cirrhosis with Ascites , 1994, Seminars in liver disease.

[4]  G. Laffi,et al.  Pathogenesis and Management of the Hepatorenal Syndrome , 1994, Seminars in liver disease.

[5]  W. Jiménez,et al.  Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. , 1993, Gastroenterology.

[6]  W. Jiménez,et al.  Brachial and femoral artery blood flow in cirrhosis: Relationship to kidney dysfunction , 1993, Hepatology.

[7]  K. Badr,et al.  Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. , 1992, The New England journal of medicine.

[8]  H. Ensinger,et al.  Relationship between infusion rates, plasma concentrations, and cardiovascular and metabolic effects during the infusion of norepinephrine in healthy volunteers , 1992, Critical care medicine.

[9]  W. Jiménez,et al.  Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin. , 1992, Journal of hepatology.

[10]  S. Badalamenti,et al.  Renal effects in cirrhotic patients with avid sodium retention of atrial natriuretic factor injection during norepinephrine infusion , 1992, Hepatology.

[11]  B. Schneeweiss,et al.  Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis: Effects on renal hemodynamics and atrial natriuretic factor , 1991 .

[12]  R. Moreau,et al.  Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis , 1991, Hepatology.

[13]  J. Reid,et al.  Impaired pressor reactivity in cirrhosis: Evidence for a peripheral vascular defect , 1991, Hepatology.

[14]  E. Van Cutsem,et al.  Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration. , 1990, Journal of hepatology.

[15]  J. Prieto,et al.  Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. , 1989, Gastroenterology.

[16]  K. Lenz,et al.  Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis. , 1989, Gut.

[17]  Vicente Arroyo,et al.  Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis , 1988, Hepatology.

[18]  P. Angeli,et al.  Effects of iloprost, a prostacyclin analog derivative, on renal plasma flow, renal function, and renin‐aldosterone system in humans , 1988, Clinical pharmacology and therapy.

[19]  M. Rosen,et al.  Comparison of the effects of dopamine, dobutamine, and dopexamine upon renal blood flow: a study in normal healthy volunteers. , 1988, British journal of clinical pharmacology.

[20]  R. Schrier,et al.  Sodium excretion in advanced cirrhosis: Effect of expansion of central blood volume and suppression of plasma aldosterone , 1986, Hepatology.

[21]  B. Groves,et al.  Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients. , 1985, Kidney international.

[22]  V. Arroyo,et al.  Sympathetic nervous activity, renin‐angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion , 1983, European journal of clinical investigation.

[23]  J. Ekstrand,et al.  Dopamine Infusion in Man. Plasma Catecholamine Levels and Pharmacokinetics , 1981, Acta anaesthesiologica Scandinavica.

[24]  G. Fitzgerald,et al.  Prostacyclin stimulates the renin angiotensin aldosterone system in man. , 1979, The Journal of clinical endocrinology and metabolism.

[25]  T. Reynolds,et al.  Effect of indomethacin and prostaglandin A, on renal function and plasma renin activity in alcoholic liver disease , 1979 .

[26]  E. Keeffe,et al.  Response to dopamine hydrochloride in the hepatorenal syndrome. , 1975, Archives of internal medicine.

[27]  A. Arieff,et al.  Renal function in cirrhosis and the effects of prostaglandin A. , 1974, The American journal of medicine.

[28]  W. Baldus,et al.  Effects of dopamine on renal function in patients with cirrhosis. , 1970, Gastroenterology.

[29]  R. Mcdonald,et al.  EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW. , 1964, The Journal of clinical investigation.

[30]  W. Jiménez,et al.  Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure. , 1993, Journal of hepatology.

[31]  J. Llach,et al.  Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites: Effect of increasing systemic arterial pressure , 1992 .

[32]  B. Schneeweiss,et al.  Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis , 1991 .

[33]  C. Patrono,et al.  Evidence for a direct stimulatory effect of prostacyclin on renin release in man. , 1982, The Journal of clinical investigation.